(Q44441964)

English

Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy

scientific article published on June 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

10.1093/NDT/GFG113

https://api.crossref.org/works/10.1093/NDT/GFG113

2 January 2024

author name string

Momir Polenakovic

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ladislava Grcevska

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sonja Dzikova

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1233-1234

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Mycophenolate mofetil: implications for the treatment of glomerular disease

1

1 reference

10.1093/NDT/GFG113

https://api.crossref.org/works/10.1093/NDT/GFG113

2 January 2024

Mycophenolate mofetil treatment for primary glomerular diseases

2

1 reference

10.1093/NDT/GFG113

https://api.crossref.org/works/10.1093/NDT/GFG113

2 January 2024

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

3

1 reference

10.1093/NDT/GFG113

https://api.crossref.org/works/10.1093/NDT/GFG113

2 January 2024

Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion.

4

1 reference

10.1093/NDT/GFG113

https://api.crossref.org/works/10.1093/NDT/GFG113

2 January 2024

Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.

5

1 reference

10.1093/NDT/GFG113

https://api.crossref.org/works/10.1093/NDT/GFG113

2 January 2024

A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis

6

1 reference

10.1093/NDT/GFG113

https://api.crossref.org/works/10.1093/NDT/GFG113

2 January 2024

Identifiers

10.1093/NDT/GFG113

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44441964&oldid=2043547252"